Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

314
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

31
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
31
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

46
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
46
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

53
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
53
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aberrant and Ectopic Cell Populations in Restrictive Allograft Syndrome after Lung Transplantation.

The European respiratory journal·2026
Same author

Non-Aspergillus fumigatus mould infections in lung transplant recipients: an international, multicentre, case-control study.

The Lancet. Microbe·2026
Same author

Direct oral anticoagulant use and drug-drug interactions in transplant recipients receiving calcineurin inhibitors.

Journal of thrombosis and haemostasis : JTH·2026
Same author

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same author

Determinants of Baseline Lung Allograft Dysfunction and its Long-term Impact on Pulmonary Function After Bilateral Lung Transplantation.

Transplantation·2026
Same author

Blood vessels as primary site of rejection in murine lung transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Related Experiment Video

Updated: Aug 10, 2025

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

20.6K

Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction.

Hanne Beeckmans1, Saskia Bos2, Robin Vos3

  • 1Department of Chronic Diseases and Metabolism, KU Leuven, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Leuven, Belgium.

Clinics in Chest Medicine
|February 11, 2023
PubMed
Summary

Lung transplant recipients face high rejection rates. This review covers acute cellular rejection and chronic lung allograft dysfunction, key challenges to long-term survival after lung transplantation.

Keywords:
Acute cellular rejectionBronchiolitis obliterans syndromeChronic lung allograft dysfunctionLung transplantationRestrictive allograft syndromeT-cell-mediated rejection

More Related Videos

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

963
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.9K

Related Experiment Videos

Last Updated: Aug 10, 2025

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

20.6K
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

963
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.9K

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Pulmonology

Background:

  • Lung transplantation is a vital treatment for end-stage respiratory diseases.
  • Lung transplant recipients experience the highest rates of acute and chronic rejection.
  • Allograft decline is common due to alloimmune responses and post-transplant injuries.

Purpose of the Study:

  • To review current knowledge on acute cellular rejection (ACR) and chronic lung allograft dysfunction (CLAD).
  • To identify barriers and knowledge gaps in managing ACR and CLAD.
  • To address the primary impediments to long-term survival in lung transplant recipients.

Main Methods:

  • Literature review of current research on lung transplant rejection.
  • Analysis of factors contributing to alloimmune recognition and allograft remodeling.
  • Synthesis of information on pathophysiological decline in lung allografts.

Main Results:

  • ACR and CLAD remain significant challenges in lung transplantation.
  • Multifactorial injuries precipitate immune-driven remodeling of the bronchovascular axis.
  • Most recipients experience functional and/or structural allograft decline.

Conclusions:

  • Understanding and overcoming ACR and CLAD are critical for improving long-term lung transplant outcomes.
  • Addressing knowledge gaps in rejection mechanisms is essential.
  • Reducing the impact of alloimmune recognition and injury is key to enhancing post-transplant survival.